in this issue
Chemical Week Magazine :: Business & Finance :: Europe/Mideast
Glaxo and Novartis to swap assets in major three-part deal
April 28, 2014 | —Natasha Alperowicz
GlaxoSmithKline (GSK) has announced a major, three-part transaction with Novartis involving its consumer health-care, vaccines, and oncology businesses. GSK and Novartis, as part of the transaction, will create a world-leading, consumer health-care joint venture with 2013 pro forma revenues of £6.5 billion ($10.9 billion)....
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee